欧盟与日本自信面对美国药品关税 称此前协议确保税率不会超过15%

Core Viewpoint - The European Union and Japan have confirmed that the United States has set limits on tariffs for pharmaceuticals, ensuring that the tax rate will not exceed 15% as per a trade agreement reached in July [1] Group 1: Tariff Agreements - The European Commission cited a joint statement from the trade agreement with the U.S., which specifies that tariffs on pharmaceuticals, semiconductors, and timber will not exceed 15% [1] - The EU is the only trade partner of the U.S. to achieve this tariff cap, providing assurance to European exporters that they will not face higher tariffs [1] Group 2: U.S. Tariff Measures - President Trump announced a new round of tariffs, including a 100% tariff on pharmaceuticals unless pharmaceutical companies establish manufacturing plants in the U.S. [1] - Additional tariffs include 25% on trucks and 30%-50% on furniture [1] Group 3: Company Responses - Swiss pharmaceutical company Roche has initiated the construction of a new factory in the U.S. [1] - Another Swiss company, Novartis, has committed to significant investments in the U.S. earlier this year, although it has not provided immediate comments regarding the new tariffs [1] - Industry insiders speculate that the newly announced tariffs may not apply to Roche and Novartis based on preliminary statements from the U.S. [1]